Keller Rohrback Investigates Overcharges for Hepatitis C Drugs

Keller Rohrback Investigates Overcharges for Hepatitis C Drugs

Keller Rohrback Investigates Overcharges for Hepatitis C Drugs   January 27, 2017 According to the results of a recent congressional inquiry, Gilead Sciences Inc.—the maker of the two popular drugs for hepatitis C patients, Sovaldi and Harvoni—chose to pursue “
Website Design by 3Circle Media